S Muoio & Company Has Raised Its Clarcor (CLC) Position; Biolife Solutions (BLFS) Shorts Raised By 7.43% – HuronReport

August 18, 2017 - By Hazel Jackson

Biolife Solutions Incorporated (NASDAQ:BLFS) had an increase of 7.43% in short interest. BLFSs SI was 245,800 shares in August as released by FINRA. Its up 7.43% from 228,800 shares previously. With 22,800 avg volume, 11 days are for Biolife Solutions Incorporated (NASDAQ:BLFS)s short sellers to cover BLFSs short positions. The SI to Biolife Solutions Incorporateds float is 3.89%. The stock decreased 5.23% or $0.24 on August 18, reaching $4.35. About 168,018 shares traded or 15.97% up from the average. BioLife Solutions Inc (NASDAQ:BLFS) has risen 37.27% since August 18, 2016 and is uptrending. It has outperformed by 20.57% the S&P500.

S Muoio & Company increased Clarcor Inc (CLC) stake by 38.27% reported in 2016Q4 SEC filing. S Muoio & Company acquired 4,000 shares as Clarcor Inc (CLC)s stock 0.00%. The S Muoio & Company holds 14,452 shares with $1.19 million value, up from 10,452 last quarter. Clarcor Inc now has $4.06B valuation. It is 0.00% or $0 reaching $0 per share. It is down 0.00% since August 18, 2016 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 2.33 in 2016 Q4. Its up 0.83, from 1.5 in 2016Q3. It is positive, as 3 investors sold BioLife Solutions Inc shares while 0 reduced holdings. 5 funds opened positions while 2 raised stakes. 267,289 shares or 5.47% less from 282,746 shares in 2016Q3 were reported. Blackrock Fund Advsrs has 0% invested in BioLife Solutions Inc (NASDAQ:BLFS) for 2,526 shares. Community Financial Bank Na stated it has 0% in BioLife Solutions Inc (NASDAQ:BLFS). Deutsche National Bank & Trust Ag reported 1 shares. Retail Bank Of America De holds 0% in BioLife Solutions Inc (NASDAQ:BLFS) or 1 shares. Tower Cap Limited Liability (Trc) invested in 0% or 862 shares. Price T Rowe Assoc Incorporated Md has invested 0% in BioLife Solutions Inc (NASDAQ:BLFS). Citadel Advsrs Ltd Liability Company accumulated 16,710 shares. Creative Planning holds 143 shares. Hudock Group Limited Liability Company reported 43 shares. Pnc Financial Group holds 0% or 10,000 shares in its portfolio. The California-based Wells Fargo & Mn has invested 0% in BioLife Solutions Inc (NASDAQ:BLFS). 2,500 are owned by Ancora Limited Liability Company. Vanguard Gru has invested 0% in BioLife Solutions Inc (NASDAQ:BLFS). Blackrock Institutional Na holds 0% of its portfolio in BioLife Solutions Inc (NASDAQ:BLFS) for 33,039 shares. Perkins holds 10,000 shares or 0.02% of its portfolio.

BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The company has market cap of $57.54 million. The Companys product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. It currently has negative earnings.

Among 2 analysts covering BioLife Solutions (NASDAQ:BLFS), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioLife Solutions had 4 analyst reports since June 14, 2017 according to SRatingsIntel. The company was maintained on Friday, August 11 by Maxim Group. The stock of BioLife Solutions Inc (NASDAQ:BLFS) earned Buy rating by Maxim Group on Monday, July 31. The company was upgraded on Wednesday, July 5 by Janney Capital. The stock of BioLife Solutions Inc (NASDAQ:BLFS) has Buy rating given on Wednesday, June 14 by Maxim Group.

Investors sentiment decreased to 0.84 in Q4 2016. Its down 0.29, from 1.13 in 2016Q3. It worsened, as 30 investors sold CLC shares while 92 reduced holdings. 42 funds opened positions while 61 raised stakes. 41.40 million shares or 3.54% less from 42.91 million shares in 2016Q3 were reported. Rhumbline Advisers has invested 0.02% of its portfolio in CLARCOR Inc. (NYSE:CLC). Champlain Prns Limited Co owns 2.01 million shares. Qs Invsts Limited Liability Company owns 0% invested in CLARCOR Inc. (NYSE:CLC) for 6 shares. Tower Rech Capital Lc (Trc) stated it has 0.02% in CLARCOR Inc. (NYSE:CLC). Tcw Grp holds 12,484 shares or 0.01% of its portfolio. Metropolitan Life Ins New York owns 77,248 shares or 0.05% of their US portfolio. Kcg Incorporated holds 0.01% of its portfolio in CLARCOR Inc. (NYSE:CLC) for 5,211 shares. Pillar Pacific Cap Mgmt Limited Liability invested in 0.07% or 5,800 shares. Barclays Public Llc invested 0% of its portfolio in CLARCOR Inc. (NYSE:CLC). Gabelli Funds Ltd Limited Liability Company has invested 0.43% in CLARCOR Inc. (NYSE:CLC). Gardner Lewis Asset Mgmt Limited Partnership holds 0.43% or 67,851 shares. Tru Communications Of Vermont reported 4,389 shares. Swiss Bankshares stated it has 80,200 shares. 7,300 were reported by Weik Invest Services. Teachers Retirement Of The State Of Kentucky accumulated 10,300 shares.

S Muoio & Company decreased Frontier Communications Corp Ser B (NASDAQ:FTR) stake by 500,000 shares to 299,192 valued at $1.01M in 2016Q4. It also reduced Gannett Co Inc stake by 52,523 shares and now owns 47,058 shares. Amc Networks Inc (NASDAQ:AMCX) was reduced too.

Among 4 analysts covering CLARCOR (NYSE:CLC), 0 have Buy rating, 2 Sell and 2 Hold. Therefore 0 are positive. CLARCOR had 8 analyst reports since August 12, 2015 according to SRatingsIntel. The stock of CLARCOR Inc. (NYSE:CLC) earned Hold rating by Zacks on Tuesday, August 18. The stock has Sell rating by Zacks on Wednesday, August 12. The firm has Sell rating by Gabelli given on Friday, December 2. On Monday, August 31 the stock rating was upgraded by Zacks to Sell. Robert W. Baird downgraded CLARCOR Inc. (NYSE:CLC) rating on Friday, September 18. Robert W. Baird has Neutral rating and $53 target. The firm has Sell rating given on Tuesday, September 22 by Zacks. The firm earned Hold rating on Tuesday, September 22 by TheStreet. The stock of CLARCOR Inc. (NYSE:CLC) has Neutral rating given on Friday, September 16 by Robert W. Baird.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Excerpt from:
S Muoio & Company Has Raised Its Clarcor (CLC) Position; Biolife Solutions (BLFS) Shorts Raised By 7.43% - HuronReport